Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Assets Average (2016 - 2025)

Historic Assets Average for Bristol Myers Squibb (BMYMP) over the last 16 years, with Q4 2025 value amounting to $93.5 billion.

  • Bristol Myers Squibb's Assets Average rose 35.11% to $93.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $93.5 billion, marking a year-over-year increase of 35.11%. This contributed to the annual value of $91.3 billion for FY2025, which is 272.74% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Assets Average of $93.5 billion as of Q4 2025, which was up 35.11% from $95.8 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Assets Average's 5-year high stood at $115.5 billion during Q1 2021, with a 5-year trough of $92.4 billion in Q3 2023.
  • Moreover, its 5-year median value for Assets Average was $96.3 billion (2024), whereas its average is $99.2 billion.
  • In the last 5 years, Bristol Myers Squibb's Assets Average tumbled by 1326.11% in 2021 and then soared by 314.59% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Assets Average (Quarter) stood at $110.1 billion in 2021, then fell by 11.44% to $97.5 billion in 2022, then fell by 4.41% to $93.2 billion in 2023, then decreased by 0.08% to $93.1 billion in 2024, then increased by 0.35% to $93.5 billion in 2025.
  • Its last three reported values are $93.5 billion in Q4 2025, $95.8 billion for Q3 2025, and $93.6 billion during Q2 2025.